Amir Sabet

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Ankylosing Spondylitis

Neuroendocrine Tumors

Ischemia Reperfusion Injury

Top Venues

Pharmaceuticals (Basel, Switzerland)

Current oncology (Toronto, Ont.)

EJNMMI research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Bellendorf, Nicolai Mader, Stefan P Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D Pöppel, Amir Sabet
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90 Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Alexander Bellendorf, Nicolai Mader, Stefan P Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D Pöppel, Amir Sabet
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90 Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Alexander Bellendorf, Nicolai Mader, Stefan P Mueller, Samer Ezziddin, Andreas Bockisch, Hong Grafe, Jan Best, Juliane Goebel, Thorsten D Pöppel, Amir Sabet
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90 Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Nicolai Mader, Christina Schoeler, Niloufar Pezeshkpour, Konrad Klimek, Daniel Groener, Christian Happel, Nikolaos Tselis, Philipp Mandel, Frank Grünwald, Amir Sabet
Intermittent Radioligand Therapy with 177 Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer. Cancers 15 (18) (2023)
Nicolai Mader, Christina Nguyen Ngoc, Bilge Kirkgöze, Justus Baumgarten, Daniel Groener, Konrad Klimek, Christian Happel, Nikolaos Tselis, Felix K H Chun, Frank Grünwald, Amir Sabet
Extended therapy with [ 177 Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer. European journal of nuclear medicine and molecular imaging (2023)
Daniel Groener, Sina Schneider, Justus Baumgarten, Christian Happel, Konrad Klimek, Nicolai Mader, Christina Nguyen Ngoc, Jennifer Wichert, Philipp Mandel, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Baseline [ 68 Ga]Ga-PSMA-11 PET/CT before [ 177 Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions. Cancers 15 (2) (2023)
Daniel Groener, Sina Schneider, Justus Baumgarten, Christian Happel, Konrad Klimek, Nicolai Mader, Christina Nguyen Ngoc, Jennifer Wichert, Philipp Mandel, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Baseline [ 68 Ga]Ga-PSMA-11 PET/CT before [ 177 Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions. Cancers 15 (2) (2023)
Daniel Groener, Sina Schneider, Justus Baumgarten, Christian Happel, Konrad Klimek, Nicolai Mader, Christina Nguyen Ngoc, Jennifer Wichert, Philipp Mandel, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Baseline [ 68 Ga]Ga-PSMA-11 PET/CT before [ 177 Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions. Cancers 15 (2) (2023)
Daniel Groener, Jennifer Wichert, Magdalena Adams, Nicolai Mader, Konrad Klimek, Christina Nguyen Ngoc, Justus Baumgarten, Christian Happel, Philipp Mandel, Felix K H Chun, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Impact of [ 177 Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [ 68 Ga]Ga-PSMA-11-PET/CT. Cancers 15 (15) (2023)
Daniel Groener, Sina Schneider, Justus Baumgarten, Christian Happel, Konrad Klimek, Nicolai Mader, Christina Nguyen Ngoc, Jennifer Wichert, Philipp Mandel, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Baseline [ 68 Ga]Ga-PSMA-11 PET/CT before [ 177 Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions. Cancers 15 (2) (2023)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Justus Baumgarten, Daniel Groener, Christina Nguyen Ngoc, Nicolai Mader, Maximilian Chaurasia, Karen Davis, Jennifer Wichert, Felix K H Chun, Nikolaos Tselis, Christian Happel, Frank Grünwald, Amir Sabet
Safety and Efficacy of 177 Lutetium-PSMA-617 Radioligand Therapy Shortly after Failing 223 Radium-Dichloride. Cancers 14 (3) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Justus Baumgarten, Christian Happel, Daniel Groener, Jennifer Staudt, Benjamin Bockisch, Amir Sabet, Frank Grünwald, Thomas Rink
Retrospective Analysis of the Development of Human Thyroglobulin during Pregnancy in Patients with Treated Non-Recurrent Differentiated Thyroid Cancer. Current oncology (Toronto, Ont.) 29 (6) (2022)
Amina Banda, Bastiaan M Privé, Youssra Allach, Maike J M Uijen, Steffie M B Peters, Cato C Loeff, Martin Gotthardt, Constantijn H J Muselaers, J Alfred Witjes, Inge M van Oort, J P Michiel Sedelaar, Harm Westdorp, Niven Mehra, Fadi Khreish, Samer Ezziddin, Amir Sabet, Michael Christoph Kreissl, Thomas Winkens, Philipp Seifert, Marcel J R Janssen, Willemijn A M van Gemert, James Nagarajah
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study. Cancers 15 (1) (2022)
Daniel Groener, Justus Baumgarten, Sebastian Haefele, Christian Happel, Konrad Klimek, Nicolai Mader, Christina Nguyen Ngoc, Nikolaos Tselis, Felix K H Chun, Frank Grünwald, Amir Sabet
Salvage Radioligand Therapy with Repeated Cycles of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement. Cancers 13 (16) (2021)
Fadi Khreish, Mona Wiessner, Florian Rosar, Zaidoon Ghazal, Amir Sabet, Stephan Maus, Johannes Linxweiler, Mark D Bartholomä, Samer Ezziddin
Response Assessment and Prediction of Progression-Free Survival by 68Ga-PSMA-11 PET/CT Based on Tumor-to-Liver Ratio (TLR) in Patients with mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy. Biomolecules 11 (8) (2021)
Amir Sabet, Nicolai Mader, Jörg Thomas Bittenbring, Fadi Khreish, Frank Grünwald, Hans Jürgen Biersack, Samer Ezziddin
Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Nicolai Mader, Daniel Groener, Nikolaos Tselis, Séverine Banek, James Nagarajah, Frank Grünwald, Amir Sabet
Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer. Cancers 13 (16) (2021)
Daniel Groener, Cam Tu Nguyen, Justus Baumgarten, Benjamin Bockisch, Karen Davis, Christian Happel, Nicolai Mader, Christina Nguyen Ngoc, Jennifer Wichert, Severine Banek, Philipp Mandel, Felix K H Chun, Nikolaos Tselis, Frank Grünwald, Amir Sabet
Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer. EJNMMI research 11 (1) (2021)